Search

Your search keyword '"Lord, Joanne"' showing total 352 results

Search Constraints

Start Over You searched for: Author "Lord, Joanne" Remove constraint Author: "Lord, Joanne"
352 results on '"Lord, Joanne"'

Search Results

1. A data‐driven examination of apathy and depressive symptoms in dementia with independent replication

3. Long-term clinical outcomes and cost-effectiveness of catheter vs thoracoscopic surgical ablation in long-standing persistent atrial fibrillation using continuous cardiac monitoring: CASA-AF randomized controlled trial

4. Circular-SWAT for deep learning based diagnostic classification of Alzheimer's disease: application to metabolome data

6. Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau

7. Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease

9. Long-term clinical outcomes and cost-effectiveness of catheter vs thoracoscopic surgical ablation in long-standing persistent atrial fibrillation using continuous cardiac monitoring: CASA-AF randomized controlled trial.

10. Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial

11. Statistical methods for body mass index: a selective review of the literature

12. Accelerating rates of cognitive decline and imaging markers associated with &bgr;-amyloid pathology

13. Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy

14. Periventricular hyperintensities are associated with elevated cerebral amyloid

15. Memory, executive, and multidomain subtle cognitive impairment

16. Brain structure and function as mediators of the effects of amyloid on memory

17. Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures

18. Mild cognitive impairment with suspected nonamyloid pathology (SNAP)

19. Circular-SWAT for deep learning based diagnostic classification of Alzheimer's disease: application to metabolome data

21. Vascular burden and Alzheimer disease pathologic progression

22. Predicting missing biomarker data in a longitudinal study of Alzheimer disease

23. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans.

24. Engaging adolescents in changing behaviour (EACH-B): a study protocol for a cluster randomised controlled trial to improve dietary quality and physical activity

25. Altering product placement to create a healthier layout in supermarkets: Outcomes on store sales, customer purchasing, and diet in a prospective matched controlled cluster study

28. Prognostic relevance of gait-related cognitive functions for dementia conversion in amnestic mild cognitive impairment

30. Type 2 diabetes mellitus, brain atrophy, and cognitive decline

32. 18F-florbetapir Positron Emission Tomography–determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery

33. CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial

34. Catheter Ablation versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF): study protocol for a randomised controlled trial

35. Cemiplimab for treating cutaneous squamous cell carcinoma (CDF review TA592)

39. LB-469804-02 LONG-TERM OUTCOMES IN LONG STANDING PERSISTENT ATRIAL FIBRILLATION FOLLOWING CATHETER OR THORACOSCOPIC SURGICAL ABLATION USING CONTINUOUS MONITORING: 3-YEAR FOLLOW-UP OF THE CASA-AF RANDOMISED CONTROLLED TRIAL

40. Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment

42. Additional file 4 of Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease

43. Additional file 2 of Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease

44. Additional file 5 of Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease

45. Additional file 3 of Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease

46. Additional file 1 of Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease

Catalog

Books, media, physical & digital resources